(Q53801644)

19 May 2018

title

Flow cytometric determination of atypical antigen expression in acute leukemia for the study of minimal residual disease. (English)

1 reference

19 May 2018

1 reference

1 reference

1 reference

Drach J

1

1 reference

19 May 2018

Drach D

2

1 reference

19 May 2018

Glassl H

3

1 reference

19 May 2018

Gattringer C

4

1 reference

19 May 2018

Huber H

5

1 reference

19 May 2018

publication date

1 January 1992

1 reference

19 May 2018

number of pages

9

1 reference

inferred from page(s)

published in

Cytometry

1 reference

19 May 2018

volume

13

1 reference

19 May 2018

issue

8

1 reference

19 May 2018

page(s)

893-901

1 reference

19 May 2018

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990130813

7 January 2021

Minimal residual disease in acute lymphoblastic leukemia detected by immune selection and gene rearrangement analysis

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990130813

7 January 2021

Detection and quantitation of neoplastic cells in acute lymphoblastic leukaemia, by use of the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990130813

7 January 2021

Combined flow cytometric assessment of cell surface antigens and nuclear TdT for the detection of minimal residual disease in acute leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990130813

7 January 2021

Follow-up of residual disease (MRD) in B lineage acute leukaemias using a simplified PCR strategy: evolution of MRD rather than its detection is correlated with clinical outcome

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990130813

7 January 2021

Acute leukaemia with mixed lymphoid and myeloid phenotype.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990130813

7 January 2021

Phenotyping of acute myelomonocytic (AMMOL) and monocytic leukemia (AMOL): association of T-cell-related antigens and skin-infiltration in AMOL

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990130813

7 January 2021

Gene rearrangements as markers of clonal variation and minimal residual disease in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990130813

7 January 2021

Minimal residual disease in childhood B-lineage lymphoblastic leukemia. Persistence of leukemic cells during the first 18 months of treatment

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990130813

7 January 2021

Identifiers

DOI

10.1002/CYTO.990130813

1 reference

19 May 2018

1 reference

19 May 2018